Exosome-encapsulated miR-29 (Exo/miR-29), administrated by intramuscular injection on mouse models, evidenced attenuated renal fibrosis through direct TGF-β1 inhibition [60]. The gene discussed is TGFB1; the disease is renal fibrosis.